Patent · US Active

Pyrrolopyrazole, potent kinase inhibitors

US8067591B2 · kind B2 · utility

2Cited by
7References
2Claims
0Family size

Assignees

Inventors

Key dates

Filing dateDec 28, 2005
Grant dateNov 29, 2011
Priority date—
Expiry dateMay 17, 2028

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Pyrrole pyrazole compounds of formula I, compositions including these compounds and methods of their use are provided. Preferred compounds of formula I have activity as protein kinase inhibitors, including as inhibitors of PAK4.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.